CAPR Capricor Therapeutics, Inc.
$8.37▲ +0.84%
Healthcare
Other
After hours
$8.37▲ +0.00%
Sep 11, 7:53 PM ET
Volume 2.07M
Avg Volume (10D) 4.83M
Key Metrics & Fundamentals
Market Cap
$486.62M
P/E Ratio
–
Div Yield
–%
52W Range
2.96 - 40.37
% vs 50 MA
-26.09%
% vs 200 MA
-64.27%
RSI-14
44.3
MACD Histogram
+0.3000
Beta (1Y vs SPY)
1.08
Free Cash Flow
-$37.39M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$44.60M
COGS
–
Operating Exp
$42.95M
Operating Income
-$42.95M
EBIT
-$42.95M
Pretax Income
-$40.73M
Net Income
-$40.73M
EPS (Diluted)
-0.70
Price & Volume History
Loading chart…
Recent News
CAPR Stock Skyrockets 144% in a Month: What Is Driving the Rally?
Zacks · Sep 7, 2026 1:28 PM
Could New Long-Term Data Support Capricor’s Duchenne Therapy?
Insider Monkey · Sep 5, 2026 12:44 AM
Sector Update: Healthcare Stocks Advance Late Afternoon
MT Newswires · Sep 1, 2026 7:46 PM
Sector Update: Healthcare
MT Newswires · Sep 1, 2026 7:27 PM
Capricor Therapeutics Shares Rise After Piper Sandler Upgrade
MT Newswires · Sep 1, 2026 6:13 PM
Capricor Therapeutics shares rise 2.5% following August FDA update
InvestorsHub · Sep 1, 2026 10:55 AM
Why Is CAPR Stock Rising Today? Piper Sandler Says Risk-Reward Favors Owning Stock Into FDA Decision
Stocktwits · Sep 1, 2026 10:52 AM
Piper Sandler Upgrades Capricor Therapeutics to Overweight From Neutral, Adjusts PT to $25 From $2
MT Newswires · Sep 1, 2026 10:29 AM
SRPT On Track For Best Week In 5 Months Ahead Of Late-2026 Clinical Data — Retail Eyes ‘Monumental Comeback’
Stocktwits · Aug 27, 2026 7:00 PM
A Rejected Vote Pushes Capricor (CAPR) Toward A Narrower Path
Insider Monkey · Aug 27, 2026 2:25 PM
Financial Overview - Income Statement
Quarterly
Dec 2024
See CAPR's money flow as a full page
Social Sentiment
Avg +0.78 · 18 posts
DDNewsDiscussionCAPR - Capricor Therapeutics - 100%+ Short Float of Retail Shares - Long Setup
r/stocks · Jul 17, 2026
High short interest, FDA approval anticipation, and potential catalysts create a bullish outlook.
positive
+0.80
DDNewsDiscussionTradePriceTargetCAPRICOR AdComm - Upside - Short Interest - Long Thesis
r/investing · Jul 16, 2026
The author is strongly bullish, outlining a clear investment thesis based on positive data, short interest, and upcoming FDA approvals.
very_positive
+0.90
NewsDiscussionTradeCapricor - FDA Insight and New Headquarter Long Term Lease
r/stocks · Jul 15, 2026
The sentiment is strongly positive due to FDA approval expectations and lease agreement details.
positive
+0.80
CAPR: My Current Favorite Biotech
r/stocks · Apr 19, 2026
The author expresses strong confidence in CAPR's FDA approval and future stock price, indicating a bullish sentiment.
positive
+0.80
TradeDDYear(s) in review
r/wallstreetbets · Dec 22, 2025
The author states they 'beat the S&P' and benefited from a CAPR purchase, indicating a positive view.
positive
+0.60
Page 1 of 4 (18 total)
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.